Overview

Amgen Australia Pty Ltd is a foreign-owned private company that generates its revenue from the importation and distribution of pharmaceutical products. The company employs approximately 210 people in Australia and is headquartered in North Ryde, New South Wales.

Amgen Australia Pty Ltd's ultimate parent is Amgen Inc, a US-based multinational biopharmaceutical company.

Amgen Australia Pty Ltd distributes the following pharmaceutical products:

  • Aranesp
  • BLINCYTO
  • IMLYGIC
  • KYPROLIS
  • Neulasta
  • NEUPOGEN
  • Nplate
  • Vectibix
  • Prolia
  • Repatha
  • Sensipar
  • XGEVA

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

This Company Has Operations in the Following Industries:

Pharmaceuticals Wholesaling in Australia

Table of Contents

Company Details
Key Personnel
Financials
Growth & Ratios
Segments
Shareholders
Subsidiaries
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.

clear